Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a…
Women with bladder or kidney cancer may lose out on a prompt diagnosis if they…
The first report from a phase II, multi-centre clinical trial indicates that a newer and…
A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological…
Personalised treatment plans may extend life expectancy for early-stage kidney cancer patients who have risk…
With the swift introduction of approved immunotherapy approaches into the treatment landscape for many cancers,…
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the…
Scientists have discovered that a marker in the blood could help predict the risk that…
I love a good plenary session at ASCO, and this year’s plenary session was one…